ResearcherColumbia UniversityActive in the last 2 years
Kensuke Suzuki
Matched on ORCID iD 0009-0004-8560-589X; OpenAlex author ID A5005244340. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 33
2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper
Papers 8
- Inhibition of C5a-C5aR1 axis suppresses tumour progression by enhancing antitumour immunity and chemotherapeutic effect in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41416-025-03185-0↗
- Preoperative Prediction of Long-Term Survival After Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-024-15648-4↗
- [Ⅳ. Recent Topics of Precision Medicine for Patients with Pancreatic Cancer]. Co-author PMID 39571982↗
- PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability. Co-author DOI 10.1158/2159-8290.cd-20-1098↗
- PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells. Co-author DOI 10.1038/s41388-019-0725-6↗
- Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer. Co-author DOI 10.1016/j.devcel.2018.05.025↗
- Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression. Co-author DOI 10.1002/cam4.1212↗
- Metadherin promotes metastasis by supporting putative cancer stem cell properties and epithelial plasticity in pancreatic cancer. Co-author DOI 10.18632/oncotarget.19802↗
Closest collaborators
The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shigetsugu Takano · 6 shared papers, 2017–2025 · strength 0.90
- Paper Inhibition of C5a-C5aR1 axis suppresses tumour progression by enhancing antitumour immunity and chemotherapeutic effect… DOI 10.1038/s41416-025-03185-0↗
- Paper Preoperative Prediction of Long-Term Survival After Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-024-15648-4↗
- Paper [Ⅳ. Recent Topics of Precision Medicine for Patients with Pancreatic Cancer]. PMID 39571982↗
- Masayuki Ohtsuka · 6 shared papers, 2017–2025 · strength 0.90
- Paper Inhibition of C5a-C5aR1 axis suppresses tumour progression by enhancing antitumour immunity and chemotherapeutic effect… DOI 10.1038/s41416-025-03185-0↗
- Paper Preoperative Prediction of Long-Term Survival After Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-024-15648-4↗
- Paper [Ⅳ. Recent Topics of Precision Medicine for Patients with Pancreatic Cancer]. PMID 39571982↗
- Hitoe Nishino · 4 shared papers, 2017–2024 · strength 0.54
- Paper Preoperative Prediction of Long-Term Survival After Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinom… DOI 10.1245/s10434-024-15648-4↗
- Paper [Ⅳ. Recent Topics of Precision Medicine for Patients with Pancreatic Cancer]. PMID 39571982↗
- Paper Metadherin promotes metastasis by supporting putative cancer stem cell properties and epithelial plasticity in pancreat… DOI 10.18632/oncotarget.19802↗
- Takanori Konishi · 2 shared papers, 2024 · strength 0.40
- Jason Robert Pitarresi · 3 shared papers, 2018–2021 · strength 0.27
- Paper PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells. DOI 10.1038/s41388-019-0725-6↗
- Paper PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability. DOI 10.1158/2159-8290.cd-20-1098↗
- Paper Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer. DOI 10.1016/j.devcel.2018.05.025↗
- Ryotaro Eto · 1 shared paper, 2025 · strength 0.27
- Benoît Marchand · 2 shared papers, 2019–2021 · strength 0.21
- Maximilian Reichert · 2 shared papers, 2018–2019 · strength 0.17
- Anil K. Rustgi · 2 shared papers, 2018–2019 · strength 0.17
- Basil S. Bakir · 2 shared papers, 2018–2021 · strength 0.16
- Shingo Kagawa · 2 shared papers, 2017 · strength 0.14
- Masaru Miyazaki · 2 shared papers, 2017 · strength 0.14
- Hideyuki Yoshitomi · 2 shared papers, 2017 · strength 0.14
- Katsunori Furukawa · 2 shared papers, 2017 · strength 0.14
- Robert J. Norgard · 1 shared paper, 2021 · strength 0.10
- Yoji Miyahara · 1 shared paper, 2021 · strength 0.10
- Jinyang Li · 1 shared paper, 2021 · strength 0.10
- Jun Zhao · 1 shared paper, 2021 · strength 0.10
- Ben Z. Stanger · 1 shared paper, 2021 · strength 0.10
- Anil K. Rustgi · 1 shared paper, 2021 · strength 0.10
- Anirban Maitra · 1 shared paper, 2021 · strength 0.10
- Faiyaz Notta · 1 shared paper, 2021 · strength 0.10
- Reiri Shimazaki · 1 shared paper, 2017 · strength 0.07
- Karin Feldmann · 1 shared paper, 2018 · strength 0.06
- Wilko Weichert · 1 shared paper, 2018 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.